Deepflare
Deepflare provides an AI-powered in silico platform designed to predict T-cell immunogenicity for antigen design. The software integrates proprietary models with open-source computational biology tools to help biotech and pharmaceutical companies de-risk pipelines and optimize vaccine candidates. The platform supports tasks such as increasing solubility and modifying specific protein regions for viral therapies and cancer vaccines.
Visit websiteWarsaw, Poland
AI
Biotechnology
Healthcare
SaaS
Computational Biology
Funding summary
- Total raised
- €1.5M
- Funding rounds
- 1
Investors in Deepflare
Investors on record for Deepflare. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Deepflare?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors